PERBEDAAN KARAKTERISTIK DASAR, TATALAKSANA DAN MORTALITAS PASIEN ANAK DENGAN EFUSI PLEURA SEBELUM DAN SAAT PANDEMI COVID-19 DARI TAHUN 2018-2022 DI RSUP DR. M DJAMIL PADANG
| dc.contributor.advisor | Finny, Fitry Yani | |
| dc.contributor.author | Dya, Mulya Lestari | |
| dc.date.accessioned | 2026-09-24T23:41:12Z | |
| dc.date.issued | 2023-12-01 | |
| dc.description | Dr. dr. Finny Fitry Yani, Sp. A (K) | |
| dc.description.abstract | Latar Belakang : Efusi pleura merupakan kondisi terjadinya akumulasi cairan antara pleura parietal dan pleura viseral. Efusi pleura akan dipengaruhi oleh karakteristik klinis dan tatalaksananya. Masa pandemi Covid-19 menjadi salah satu faktor risiko yang dapat mempengaruhi mortalitas dari pasien anak dengan efusi pleura di RSUP Dr. M. Djamil Padang. Tujuan : Mengetahui perbedaan karakteristik dasar (demografi, klinis dan etiologi), tatalaksana dan mortalitas sebelum dan saat pandemi Covid-19 pada pasien anak dengan efusi pleura di RSUP Dr. M. Djamil. Metode : Penelitian ini cross-sectional melalui pengambilan data pasien anak dengan efusi pleura di RSUP Dr. M. Djamil dari Februari 2018 sampai Maret 2022. Data yang lengkap terkumpul sejumlah 71 data, yang terbagi 30 pasien sebelum pandemi dan 30 pasien saat pandemi Covid-19. Hasil : Pasien anak dengan efusi pleura didapatkan dari karakteristik demografi lebih banyak laki- laki dan berusia 12-18 tahun pendidikan orangtua yang tinggi dan berasal dari provinsi Sumatera Barat pada masa sebelum dan saat pandemi Covid-19. Status gizi tidak didapatkan perbandingan sebelum dan saat pandemi Covid-19 hampir sama banyak gizi baik dengan malnutrisi. Pada karakteristik klinis didapatkan hasil yang bermakna yaitu lama keluhan sebelum masuk rumah sakit, dimana sebelum pandemi Covid-19 pasien anak dengan efusi pleura cenderung mempunyai keluhan >4 minggu lebih tinggi dibandingkan saat pandemi Covid-19 yaitu 23,3% vs 3,3% (p<0,05). Perbedaan bermakna juga terjadi pada analisis cairan pleura, dimana kadar LDH pada pasien efusi pleura saat pandemi Covid-19 lebih tinggi dibandingkan sebelum pandemi Covid-19 (p<0,05) yaitu 5.277+10.664 vs 632+1.069. Namun pada keluhan utama, dan analisis cairan pleura lainnya beserta etiologi jenis kuman cairan efusi pleura didapatkan hasil tidak bermakna (p>0,05). Berdasarkan penggunaan antibiotik pada pasien anak dengan efusi pleura, terdapat beberapa jenis antibiotik yang paling banyak digunakan sebelum dan saat pandemi Covid-19 yaitu antibiotik lini pertama seperti Ampicillin (63,3% vs 46,7%) dan Gentamicin (50,0% vs 33,3%), dan jenis antibiotik yang jarang digunakan pada sebelum dan saat pandemi Covid-19 yaitu jenis antibiotik lini ketiga seperti Meropenem, Cefepime, Cefoperazone, Ceftazidime, Amikasin, Vankomicin dan Fosfomycin. Angka mortalitas pada pasien anak dengan efusi pleura cukup tinggi, yaitu >30%. Prevalensi lebih tinggi pada saat pandemi Covid-19 (36,7%) dibandingkan sebelum pandemi Covid-19 (33,3%), namun secara statistik tidak bermakna (p>0,05). Kesimpulan : Perbedaan karakteristik dasar, tatalaksana, dan mortalitas pasien anak dengan efusi pleura tidak dipengaruhi pada masa sebelum dan saat pandemi Covid-19. Hasil signifikan didapatkan dari lama keluhan sebelum masuk rumah sakit sebelum pandemi Covid-19 lebih banyak >4 minggu dibandingkan saat pandemi Covid-19 dan kadar LDH pada cairan efusi pleura yang meningkat saat pandemi Covid-19 dibandingkan sebelum pandemi Covid-19. | |
| dc.identifier.uri | https://ailib.my.id/handle/123456789/73200 | |
| dc.language.iso | id | |
| dc.publisher | Universitaas Andalas | |
| dc.subject | Pleural effusion in pediatric | |
| dc.subject | Pleural effusion in Covid-19 | |
| dc.subject | Mortality pleural effusion in pandemic Covid-19 | |
| dc.subject.classification | RJ Pediatrics | |
| dc.title | PERBEDAAN KARAKTERISTIK DASAR, TATALAKSANA DAN MORTALITAS PASIEN ANAK DENGAN EFUSI PLEURA SEBELUM DAN SAAT PANDEMI COVID-19 DARI TAHUN 2018-2022 DI RSUP DR. M DJAMIL PADANG | |
| dc.type | Thesis | |
| dcterms.dateSubmitted | 2024-01-08 | |
| dcterms.references | DAFTAR PUSTAKA 1. Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med. 2012;31–52. 2. Goyal V, Kumar A, Gupta M, Sandhu HPS, Dhir S. Empyema thoracis in children: Still a challenge in developing countries. African J Paediatr Surg. 2014;206–10. 3. Yousef AA, Jaffe A. The management of paediatric empyema. HK J Paediatr. 2009;16–21. 4. Rostad BS, Shah JH, Rostad CA, Jaggi P, Richer EJ, Linam LE, et al. Chest radiograph features of multisystem inflammatory syndrome in children (mis-c) compared to pediatric covid-19. Pediatr Radiol. 2021;231–8. 5. Jany B, Welte T. Pleural effusion in adults - etiology, diagnosis, and treatment. Deutsches Arzteblatt International. Deutscher Arzte-Verlag GmbH; 2019.377–86. 6. Beers SL, Abramo TJ. Pleural effusions. Pediatr Emerg Care. 2007;330–8. 7. Adeoye P, Johnson W, Desalu O, Ofoegbu C, Fawibe A, Salami A, et al. Etiology, clinical characteristics, and management of pleural effusion in ilorin, nigeria. Niger Med J. 2017;76– 80. 8. Cappelli S, Casto E, Lomi M, Pagano A, Gabbrielli L, Pancani R, et al. Pleural effusion in covid-19 pneumonia: clinical pand prognostic implications - an observational, retrospective study. J Clin Med. 2023;1–8. 9. World Health Organization. Covid-19 frequently asked questions [Internet]. 2019. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ 10. Dewi R, Kaswandani N, Karyanti MR, Setyanto DB, Pudjiadi AH, Hendarto A, et al. Mortality in children with positive sars-cov-2 polymerase chain reaction test: lessons learned from a tertiary referral hospital in indonesia. Int J Infect Dis. 2021;78–85. 11. Obando I, Muñoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, et al. Pediatric parapneumonic empyema, spain. Emerg Infect Dis. 2008;1390–7. 12. Charalampidis C, Youroukou A, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, et al. Pleura space anatomy. J Thorac Dis. 2015;27-32. 13. Miserocchi G, Hamm H, Light RW. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J. 1997;219–25. 14. Efrati O, Barak A. Pleural effusions in the pediatric population. Pediatr Rev.2014;417–26. 15. Cashen K, Petersen TL. Pleural effusions and pneumothoraces practice gaps. Pediatr Rev. 2017;170–81. 16. Kallanagowdar C, Craver RD. Neonatal pleural effusion. Vol. 130, Arch Pathol Lab Med. 2006. 17. Afsharpaiman S, Izadi M, Ajudani R, Khosravi MH. Pleural effusion in children: a review article and literature review. Int J Med Rev. 2016;1–6. 18. Balfour-Lynn IM, Abrahamson E, Cohen G, Hartley J, King S, Parikh D, et al. BTS guidelines for the management of pleural infection in children. Thorax. 2005;1–21. 19. Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration. 2008;4–13. 20. Heffner JE. Diagnosis and management of malignant pleural effusions. Asian Pacific Soc Respirol. 2008;5–20. 21. Medford A, Maskell N. Pleural effusion. Postgraduate Medical Journal. 2005;702–10. 22. Yao CT, Wu JM, Liu CC, Wu MH, Chuang HY, Wang JN. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest. 2004;566– 71. 23. Boyer DM. Evaluation and management of a child with a pleural effusion. Pediatr Emerg Care. 2005;63–8. 24. Risteska-Nejashmikj V, Stojkovska S, Stavrikj K. Dyspnea in children as a symptom of acute respiratory tract infections and antibiotic prescribing. Open Access Maced J Med Sci. 2018;578–81. 25. Hussein MS, Ul Haq I, Thomas M, Allangawi M, Elarabi A, Hameed M. Pleural effusion secondary to covid-19 infection. Chest. 2020;A2442. 26. Gates RL, Hogan M, Weinstein S, Arca MJ. Drainage, fibrinolytics, or surgery: a comparison of treatment options in pediatric empyema. J Pediatr Surg. 2004;1638–42. 27. de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandão MB. Clinical manifestations of children with covid-19: a systematic review. Pediatric Pulmonology. John Wiley and Sons Inc; 2020;1892–9. 28. Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A, et al. Epidemiology and pathobiology of sars-cov-2 in comparison with sars, mers: an updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Heal. 2021;1– 10. 29. Chong WH, Saha BK, Conuel E, Chopra A. The incidence of pleural effusion in covid-19 pneumonia: state-of-the-art review. Hear Lung. 2021;481–90. 30. Moin JS, Vigod SN, Plumptre L, Troke N, Asaria M, Papanicolas I, et al. Sex differences among children, adolescents and young adults for mental health service use within inpatient and outpatient settings, before and during the covid-19 pandemic: a population-based study in ontario, canada. BMJ Open. 2023;1–9. 31. Swanepoel J, Za JA. Sars-cov-2 infection and pulmonary tuberculosis in children and adolescents: a case-control study. Open Access BMC Infect Dis. 2023;1–10. 32. Murillo-Zamora E, Trujillo X, Huerta M, Ríos-Silva M, Baltazar-Rodríguez LM, Guzmán- Esquivel J, et al. Decreased risk of covid-19 pneumonia in children and adolescents during the delta variant emergence. Public Health. 2022;9–11. 33. Sato M, Oshitani H, Tamaki R, Oyamada N, Sato K, Nadra AR, et al. Factors affecting mothers’ intentions to visit healthcare facilities before hospitalisation of children with pneumonia in Biliran province, philippines: a qualitative study. BMJ Open. 2020;1–10. 34. Mercer RM, Corcoran JP, Porcel JM. Interpreting pleural fluid results. Clin Med. 2019;213– 7. 35. Karakaya Molla G, Ünal Uzun Ö, Koç N, Özen Yeşil B, Bayhan Gİ. Evaluation of nutritional status in pediatric patients diagnosed with covid-19 infection. Clin Nutr ESPEN. 2021;44:424–8. 36. Yilmaz AE, Koktener A, Celik N, Akca H, Bilici M, Mete E. Frequency of pleural effusion in acute bronchiolitis and its effect on prognosis. Multidiscip Respir Med. 2011;371–6. 37. Roberts JE, Bezack BJ, Winger DI, Pollack S, Shah RA, Cataletto M, et al. Association between parapneumonic effusion and pericardial effusion in a pediatric cohort. Pediatrics. 2008;122(6). 38. Kheir F, Kaphle U, Ahmed F, Alraiyes AH. The pH-glucose relationship in malignant pleural effusion. Journal of Bronchology and Interventional Pulmonology.2016;17-8. 39. Golden L, Chaya S, Reichmuth K, Visagie A, Ayuk A, Owusu SK, et al. Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in south africa. African J Thorac Crit Care Med. 2021;138–44. 40. Prais D, Kuzmenko E, Amir J, Harel L. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia. Pediatrics. 2008 Mar;1–8. 41. Menzies SM, Rahman NM, Wrightson JM, Davies HE, Shorten R, Gillespie SH, et al. Blood culture bottle culture of pleural fluid in pleural infection.Thorax. 2011;66:658-62. 42. Putra TRI, Maya P, Hasan M, Pranata A, Salsabila S, Sariningrum HA. Karakteristik Pasien Efusi Pleura Non-Maligna di RSUD Dr. Zainoel Abidin Tahun 2019. Jurnal Penyakit Dalam Indonesia. 2022;9:15. 43. Ojha SC, Chen K, Yuan Y, Ahmed S, Malik AA, Nisha M, et al. Clinical relevance of molecular testing methods in the diagnosis and guidance of therapy in patients with staphylococcal empyema: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2022;1–11. 44. dos Santos E da C, da Silva J de S, de Assis Filho MTT, Vidal MB, Monte M de C, Lunardi AC. Adding positive airway pressure to mobilisation and respiratory techniques hastens pleural drainage: a randomised trial. J Physiother. 2020;19–26. 45. Oliveira JF, Mello FCQ, Rodrigues RS, Boechat AL, Conde MB, Menezes SLS. Effect of continuous positive airway pressure on fluid absorption among patients with pleural effusion due to tuberculosis. Rev Bras Fisioter. 2010;127–32. 46. Ericson JE, Hornik CP, Greenberg RG, Clark RH, Tremoulet AH, Le J, et al. Paradoxical antibiotic effect of ampicillin: use of a population pharmacokinetic model to evaluate a clinical correlate of the eagle effect in infants with bacteremia. Pediatr Infect Dis J. 2020;725–9. 47. Hollander EM, van Tuinen EL, Schölvinck EH, Bergman KA, Bourgonje AR, Gracchi V, et al. Evaluation of dosing guidelines for gentamicin in neonates and children. Antibiotics. 2023;1–16. 48. Bradley, JS. Byington, CL. Shah, SS. Alverson, B. Carter, ER. Harrison, C. The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clinical Infectious Diseases. 2011;53:e27-76. 49. Sauteur PMM, Burkhard A, Moehrlen U, Relly C, Kellenberger C, Ruoss K, et al. Pleural tap- guided antimicrobial treatment for pneumonia with parapneumonic effusion or pleural empyema in children: a single-center cohort study. J Clin Med. 2019;1–14. 50. Singh Rathore S, Hussain N, Harrison Manju A, Wen Q, Tousif S, Andrés Avendaño-Capriles C, et al. Prevalence and clinical outcomes of pleural effusion in covid-19 patients: a systematic review and meta-analysis. J Med Virol. 2022;94:229–39. 51. Das A, Khosla R. Pleural Effusion Characteristics and Mortality. Chest. 2013;144:511A. | |
| local.eprints.dir | disk0/00/46/09/72 | |
| local.eprints.division | S2 | |
| local.eprints.id | 460972 | |
| local.eprints.type | thesis/masters | |
| local.eprints.uri | http://scholar.unand.ac.id/460972/ | |
| local.fakultas | Pascasarjana (S2) | |
| local.identifier.nim | 1750304208 | |
| local.thesis.level | Tesis |
